Polymorphonuclear Neutrophil in Brain Parenchyma After Experimental Intracerebral Hemorrhage

• Published in: Translational stroke research Vol. 5; no. 5; pp. 554 - 561
• Main Authors: Zhao, Xiurong, Sun, Guanghua, Zhang, Han, Ting, Shun-Ming, Song, Shen, Gonzales, Nicole, Aronowski, Jaroslaw
• Format: Journal Article
• Language: English
• Published: Boston Springer US 01.10.2014; Springer Nature B.V
• Subjects: Animals; Antibodies; Antigens; Biomedical and Life Sciences; Biomedicine; Brain; Brain - blood supply; Brain - immunology; Cardiology; Cerebral Hemorrhage - immunology; Cerebral Hemorrhage - pathology; Disease Models, Animal; Hematoma; Hemorrhage; Ischemia; Laboratory animals; Male; Neurology; Neurosciences; Neurosurgery; Neutrophil Infiltration; Neutrophils; Neutrophils - immunology; Original Article; Rats; Rats, Sprague-Dawley; Stroke; Variance analysis; Vascular Surgery; Parenchyma; Extravasation; Intracerebral hemorrhage; Polymorphonuclear neutrophils
• ISSN: 1868-4483; 1868-601X
• DOI: 10.1007/s12975-014-0341-2

Polymorphonuclear neutrophils (PMNs) infiltration into brain parenchyma after cerebrovascular accidents is viewed as a key component of secondary brain injury. Interestingly, a recent study of ischemic stroke suggests that after ischemic stroke, PMNs do not enter brain parenchyma and as such may cause no harm to the brain. Thus, the present study was designed to determine PMNs’ behavior after intracerebral hemorrhage (ICH). Using the autologous blood injection model of ICH in rats and immunohistochemistry for PMNs and vascular components, we evaluated the temporal and spatial PMNs distribution in the ICH-affected brain. We found that, similar to ischemia, there is a robust increase in presence of PMNs in the ICH-injured tissue that lasts for at least 1 to 2 weeks. However, in contrast to what was suggested for ischemia, besides PMNs that stay in association with the vasculature, after ICH, we found abundance of intraparenchymal PMNs (with no obvious association with vessels) in the ICH core and hematoma border, especially between 1 and 7 days after the ictus. Interestingly, the increased presence of intraparenchymal PMNs after ICH coincided with the massive loss of microvascular integrity, suggesting vascular disruption as a potential cause of PMNs presence in the brain parenchyma. Our study indicates that in contrast to ischemic stroke, after ICH, PMNs target not only vascular compartment but also brain parenchyma in the affected brain. As such, it is possible that the pathogenic role and therapeutic implications of targeting PMNs after ICH could be different from these after ischemic stroke. Our work suggests the needs for more studies addressing the role of PMNs in ICH.